4-Pyridylboronic Acid CAS 1692-15-5 Ịdị Ọcha ≥99.5% (HPLC) Ụlọ Ọrụ Na-ekpo ọkụ
Onye na-emepụta ihe, ịdị ọcha dị elu, mmepụta azụmahịa
Aha Chemical: 4-Pyridylboronic AcidOZI: 1692-15-5
Aha Chemical | 4-Pyridylboronic Acid |
Ụdị okwu | Pyridine-4 - Boronic acid |
Nọmba CAS | 1692-15-5 |
Nọmba CAT | RF-PI571 |
Ọnọdụ Ahịa | Na Akụrụngwa, Ike nrụpụta 25 Tọn/ọnwa |
Usoro ihe omimi | C5H6BNO2 |
Ibu molekụla | 122.92 |
Solubility | Na-adịghị edozi n'ime mmiri |
Ebe Na-agbaze | > 300 ℃ (ọkụ) |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Ọcha ntụ ntụ |
Ụzọ ịdị ọcha / nyocha | > 99.5% (HPLC) |
Mmiri (nke Karl Fischer) | <0.50% |
Otu adịghị ọcha | <0.50% |
Mgbakọta adịghị ọcha | <0.50% |
Ọla dị arọ (dị ka Pb) | <20ppm |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Ndị na-ahụ maka ọgwụ |
ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
Enwere ike iji 4-Pyridylboronic Acid (CAS: 1692-15-5) mee ihe dị ka onye ndoro-ndoro maka mmeghachi omume njikọta nke Suzuki-Miyaura.Karịsịa, dị ka ihe mgbochi ụlọ nwere N, pyridine-4-boronic acid ka ejiri rụọ ụfọdụ ogige heterocyclic nwere ọrụ ndu dị elu.4-Pyridylboronic Acid bụ ụdị nke boronic acid ewepụtara.Ọ bara uru ihe mgbochi ụlọ na injinia kristal.A pụkwara iji ya mee ihe dị ka ihe na-eme ka ọ bụrụ ihe na-eme ka mmiri na-ekpo ọkụ na-eme ka mmiri na-ekpo ọkụ na-emepụta amides na-eji carboxylic acid na amines dị ka akụrụngwa.Mwepụta ya, polystyrene-ejikọta 4-pyridineboronic acid, bụ ihe bara uru maka mmeghachi omume amidation na esterification nke alfa-hydrocarboxylic acid.
Reagent eji maka: Palladium-catalyzed Suzuki-Miyaura mmeghachi omume njikọ;Palladium na-enweghị Ligand-catalyzed Suzuki njikọ mmeghachi omume n'okpuru ngwa ngwa irradation;Reagent eji na: Nkwadebe nke nje HIV-1 protease inhibitors;Ọgwụgwọ ọrịa kansa nwere ike, dị ka PDK1 na protein kinase CK2 inhibitors.